Outlook Therapeutics
OTLK
#9367
Rank
HK$0.69 B
Marketcap
HK$15.60
Share price
-2.20%
Change (1 day)
17.94%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2025 (TTM): HK$11.81 Million

According to Outlook Therapeutics 's latest financial reports the company's current revenue (TTM ) is HK$11.71 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$11.81 M
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 HK$55.12 M108.08%
2018 HK$26.49 M-20.78%
2017 HK$33.44 M88.5%
2016 HK$17.74 M-30.21%
2015 HK$25.41 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
HK$4.99 B 42,566.55% Jersey
Novavax
NVAX
HK$7.96 B 67,947.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$1.12 M-90.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.16 B 1,350.79%๐Ÿ‡ฌ๐Ÿ‡ง UK